Home Executive Summary Overview of Antibiotic Resistance RecA Inhibitors Re-arming Old Drugs Commercialization Management News Overview of Antibiotic Resistance The antibiotic era began in 1928 with Fleming s discovery of penicillin, but it wasn t until 1944 that the drug was mass marketed. ...

Home Executive Summary Overview of Antibiotic Resistance RecA Inhibitors Re-arming Old Drugs Commercialization Management News Commercialization Because of the high cost of clinical trials and the marketing infrastructure need to sell antibiotics, Synereca will establish partnerships with pharma...

Home Executive Summary Overview of Antibiotic Resistance RecA Inhibitors Re-arming Old Drugs Commercialization Management News Synereca Pharmaceuticals was created to address the growing problem of bacterial resistance to current antibiotics by developing orally active drugs that restore or incr...

Home Executive Summary Overview of Antibiotic Resistance RecA Inhibitors Re-arming Old Drugs Commercialization Management News RecA Inhibitors Re-arming Old Drugs RecA is a ubiquitous bacterial protein whose sequence is highly conserved across all bacteria. RecA s structure, functions, a...

Home Executive Summary Overview of Antibiotic Resistance RecA Inhibitors Re-arming Old Drugs Commercialization Management News News UNC, Synereca complete first Carolina Express License| April 9th, 2010 Synereca One of Four Startups Selected to Present at CED Streak Showcase| January 19th, 2010 ...